390 likes | 519 Vues
This case study presents the clinical journey of a 62-year-old Caucasian woman who recently migrated from Australia to England. She presented with acute respiratory distress characterized by rapid breathing, chest tightness, and episodes of hemoptysis. Past medical history includes pneumonia, while current medications consist of hormone replacement therapy. Following thorough examinations, including blood analysis and chest radiography, the patient was diagnosed with pneumonia. The case details her symptoms, clinical examination, treatment progress, and follow-up results over a week.
E N D
TAKE MY BREATH AWAY…... Ali Hasan May Harker Anna Harrison-Murray Amer Ullah
MB • A 62 year old Caucasian woman breathing quickly, who arrived in England from Australia three weeks ago • Complained of feeling “lousy”
SYMPTOMS • One episode of haemoptysis • A tight chest affecting breathing - RR 20 on admission • 3/7 before attending A+E – first presentation of illness was aching knee and ankle joints. • Left shoulder pain later emerged
ALSO … • Anorexia, nausea, and vomiting • Dizziness, with one marked episode of confusion and loss of balance • Hot and cold flushes • Feeling very tired • Hot and cold flushes • Profound lethargy • Nausea and vomiting
PAST MEDICAL HISTORY • Previous episode of pneumonia, age 31. • Hot and cold flushes – previously well • controlled by HRT. • Hallux rigidus • High cholesterol – 7.5 (normal 4 - <6).
AND … • Occasional headaches when overworked. • Neurodermatitis which has not recurred for years.
SURGICAL HISTORY • Removal of fibroadenoma in the right breast • Tubal ligation
CURRENT MEDICATION • Remifem, an OTC HRT “replacement” • ALLERGIES • An adverse reaction to voltarol which caused paraesthesia in her foot.
FAMILY HISTORY • No illnesses mentioned in daughters • Mother had a cholesterol problem, for which she had an endarterectomy – and subsequently suffered a stroke which left her senile. • Maternal grandmother died of rheumatic heart disease.
SOCIAL HISTORY • An English woman who lives in Australia • Migrated to Australia, age 17 • Lives with her husband, a cattle farmer, two daughters • Smoked for 12 pack years, age 18-35
SYSTEMS REVIEW • CVS: • No palpitations, swelling, or previous history of SOB
SYSTEMS REVIEW CONT. • Respiratory system: • No cough • No wheezing • Occasional “nasal drip”
SYSTEMS REVIEW CONT • GU System: • Increased thirst • Went to the toilet 5x/24h • No urinary urgency, and usually one episode of nocturia per night • Two past urinary infections
SYSTEMS REVIEW CONT • GI System: • Patient has not eaten, and there were no bowel motions since presentation 3/7 ago. • Patient suffered from “plenty of wind”. • No tenderness or pain.
VITAL SIGNS BP 135/69 Temp. 38.6 Pulse 100 reg RR 20 O2 Sat 91% (air) GCS 15 CLINICAL EXAMINATION CVS ° abnormalities detected Resp GI ° abnormalities detected XX XX
INVESTIGATIONS • ECG • Blood Analysis • Chest Radiography • CT Scan • Microbiology
ECG • Tachycardic sinus rhythm CHEST RADIOGRAPHY • Patchy consolidation left lung • Slight left pleural effusion CT SCAN
MICROBIOLOGY • Blood Cultures • Blood and Sputum Gram Stains • Antibiotic Sensitivity Tests • Legionella Titre
FOLLOW UP • 3/7 later • Patient appeared visibly better • IV antibiotics and fluid had been stopped – antibiotics were now oral • Nausea stopped 2/7 after admission
FOLLOW UP CONT • Chest no longer “tight”. Breaths deeper but still some pain on left side when taking very deep breaths • An intermittent dry unproductive cough appeared 2/7 after admission. No further sputum production or haemoptysis - referred to physio
MORE FOLLOW UP • Patient now eating small meals and resumed bowel movements • No further dizziness, but still the occasional flush
AND FINALLY… • Some lethargy. • Vital signs good. Pulse around 76, temp 36.6, resp rate around 15. • Discharge planned 3/7 after.
PATHOLOGY • DEFINITION • Inflammation of the lung parenchyma - exudative solidification (consolidation) • CAUSES • Bacterial (most common) Other
EPIDEMIOLOGY • Incidence of CAP - 12 per 1000 adults • CAP accounts for 5-12 % of all LRTI’s • Approximately 10% require hospitalisation
EPIDEMIOLOGY CONT • Mortality reduced by effective use of antibiotics but remains dangerous condition and a major cause of death in over 70’s • - Mx community < 1% - Mx in hospital Approximately 10%
CLASSIFICATION (1) • COMMUNITY AQCUIRED (CAP) • - Primary or secondary • - Mainly Gram +ve bacteria • HOSPITAL ACQUIRED • - Acquired > 48hrs after admission • - Mostly caused by Gram -ve bacteria • - Problem with antibiotic resistance
CLASSIFICATION (2) BY SITE • DIFFUSE (LOBULAR) • - patchy consolidation • - extension of pre-existing disease • - extremely common esp. infancy and old age • LOCALISED (LOBAR) • - involvement of large portion / entire lobe • - infrequent due to antibiotic effectiveness
CLASSIFICATION (3) • BY AETIOLOGY • COMMON ORGANISMS • - Streptococcus Pneumoniae (60-75%) • - Mycoplasma Pneumoniae (5-18%) • - Influenza A (usually with bacterial) • - Haemophilus influenzae • - Staphylococcus aureus • - Legionella species • - Chlamydia psittaci
CLINICAL FEATURES • Vary according to immune system and infecting agent • Symptoms • - Malaise • - high temp (up to 39.5) • - pleuritic pain • - dyspnoea • - cough • - purulent / rusty sputum • Signs • - fever • - cyanosis • - confusion • - tachypnoea • - tachycardia • - consolidation signs • - pleural rub
COMPLICATIONS • Respiratory failure • Hypotension • Atrial fibrilation • Pleural effusion • Empyema • Lung abscess • Organisation of exudate • Bacteremic dissemintion
Mild community acquired MANAGEMENT 1 Nonsmoking adults < 60 yrs Smoking adults & > 60 yrs Erythromycin 500 mg X 3 or Clarithromycin 250 mg x 2 Cefaclor 500 mg x3
MANAGEMENT 2 • Patients with severe pneumonia best managed on an intensive care unit Severe community acquired i.v. 6 h Cefuroxime 1.5 g & Clarithromycin 500 mg 12 h
MANAGEMENT OF MB • Severe community acquired pneumonia • No causative organism identified but L. pneumophilia Ag test (urine) negative
DRUGS 1 • Regular • CEFOTAXIME (broad spectrum antibiotic) 1g i.v. tds • ERYTHROMYCIN 500 mg oral qds • PARACETAMOL 1g oral qds • METOCLOPRAMIDE 10mg i.v. tds (for nausea - side-effect of antibiotics)
DRUGS 2 • As Required • DIHYDROCODEINE 30 mg oral (for pleuritic chest pain) • CYCLIZINE (for nausea/vomiting)50 mg oral • Saline
OTHER • O2 therapy for hypoxaemia • Fluids encouraged to avoid dehydration • Seen by chest physiotherapist due to inability to expectorate • Antibiotics shifted to oral route after 3 days of i.v.